Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study

被引:17
|
作者
Jiang, Guoqian [1 ]
Liu, Hongfang [1 ]
Solbrig, Harold R. [1 ]
Chute, Christopher G. [1 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
来源
BIODATA MINING | 2015年 / 8卷
关键词
Drug-drug Interaction; Adverse drug event; Data mining; Semantic web technology; Electronic medical records; KNOWLEDGE-BASE; REPORTING DATA; PHARMACOGENOMICS;
D O I
10.1186/s13040-015-0044-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Drug-drug interactions (DDIs) are a major contributing factor for unexpected adverse drug events (ADEs). However, few of knowledge resources cover the severity information of ADEs that is critical for prioritizing the medical need. The objective of the study is to develop and evaluate a Semantic Web-based approach for mining severe DDI-induced ADEs. Methods: We utilized a normalized FDA Adverse Event Report System (AERS) dataset and performed a case study of three frequently prescribed cardiovascular drugs: Warfarin, Clopidogrel and Simvastatin. We extracted putative DDI-ADE pairs and their associated outcome codes. We developed a pipeline to filter the associations using ADE datasets from SIDER and PharmGKB. We also performed a signal enrichment using electronic medical records (EMR) data. We leveraged the Common Terminology Criteria for Adverse Event (CTCAE) grading system and classified the DDI-induced ADEs into the CTCAE in the Web Ontology Language (OWL). Results: We identified 601 DDI-ADE pairs for the three drugs using the filtering pipeline, of which 61 pairs are in Grade 5, 56 pairs in Grade 4 and 484 pairs in Grade 3. Among 601 pairs, the signals of 59 DDI-ADE pairs were identified from the EMR data. Conclusions: The approach developed could be generalized to detect the signals of putative severe ADEs induced by DDIs in other drug domains and would be useful for supporting translational and pharmacovigilance study of severe ADEs.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Drug-drug interaction prediction: databases, web servers and computational models
    Zhao, Yan
    Yin, Jun
    Zhang, Li
    Zhang, Yong
    Chen, Xing
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (01)
  • [32] A multimodal deep learning framework for predicting drug-drug interaction events
    Deng, Yifan
    Xu, Xinran
    Qiu, Yang
    Xia, Jingbo
    Zhang, Wen
    Liu, Shichao
    BIOINFORMATICS, 2020, 36 (15) : 4316 - 4322
  • [33] Prediction of drug-drug interaction events using graph neural networks based feature extraction
    Al-Rabeah, Mohammad Hussain
    Lakizadeh, Amir
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Prediction of drug-drug interaction events using graph neural networks based feature extraction
    Mohammad Hussain Al-Rabeah
    Amir Lakizadeh
    Scientific Reports, 12
  • [35] RETRACTED: A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms (Retracted Article)
    Noor, Adeeb
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [36] Extraction of drug-drug interaction using neural embedding
    Hou, Wen Juan
    Ceesay, Bamfa
    JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, 2018, 16 (06)
  • [37] PREDICTING PACLITAXEL DRUG-DRUG INTERACTION USING SIMCYP
    Loi, C.
    Zientek, M.
    Zhong, W.
    Freiwald, S.
    Yamazaki, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S58 - S58
  • [38] Characterization of drug-drug interaction using the population approach
    Roy, A
    Ette, EI
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1064 - 1064
  • [39] Concomitant use of proton pump inhibitors and metabolically competing drugs, and the risk of drug-drug interaction induced adverse events
    McLaughlin, TP
    Yazdani, C
    Okamoto, LJ
    Tedeschi, M
    GASTROENTEROLOGY, 2001, 120 (05) : A402 - A402
  • [40] STUDY FOR DRUG-DRUG INTERACTION IN THE TREATMENT OF CHRONIC DISEASE
    Chae, Jung-Woo
    Beak, Hyun-Moon
    Song, Byung-Jeong
    Lee, Byung-Yo
    Kang, Ho-Il
    Kwon, Kwang-Il
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E205 - E205